Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America

Clinical Infectious Diseases

Volumn 54, Issue 10, 2012, Pages 1397-1405

  Desai, Rishi ^a   Parashar, Umesh D ^a   Lopman, Benjamin ^a   De Oliveira, Lucia Helena ^b   Clark, Andrew D ^c   Sanderson, Colin F B ^c   Tate, Jacqueline E ^a   Matus, Cuahtemoc Ruiz ^b   Andrus, Jon K ^b   Pate, Manish M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b PAN AMERICAN HEALTH ORGANIZATION   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; DRUG EFFECT; HUMAN; INFANT; INTUSSUSCEPTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; ROTAVIRUS INFECTION; SOUTH AND CENTRAL AMERICA; TREATMENT OUTCOME;

CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INSURANCE BENEFITS; INTUSSUSCEPTION; LATIN AMERICA; MALE; RISK ASSESSMENT; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SURVIVAL ANALYSIS; VACCINATION;

EID: 84860244914     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis191     Document Type: Article

References (73)

1. Parashar UD, Burton A, Lanata C, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009; 200(Suppl 1):S9-15.
2. de Oliveira LH, danovaro-Holliday MC, Sanwogou JN, Ruiz-Matus C, Tambini G, Andrus J. Progress in the introduction of the rotavirus vaccine in Latin America and the Caribbean: four years of accumulated experience. Pediatr Infect Dis J 2011; 30(Suppl 1):S61-6.
3. Lanzieri TM, Linhares AC, Costa I, et al. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. Int J Infect Dis 2011; 15:e206-10. Epub 28 Dec 2010.
4. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010; 362:299-305.
5. de Palma O, Cruz L, Ramos H, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010; 340:c2825.
6. Yen CY, Guardado JA, Alberto P, et al. Decline in rotavirus hospitalizations and health care visits for diarrhea among children , 5 years of age following implementation of rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011; 30(Suppl 1):S6-10.
7. Quintanar-Solares M, Yen CY, Esparza-Aguilar M, Richardson V, Parashar U, Patel MM. Impact of rotavirus vaccination on diarrhearelated hospitalizations among children , 5 years of age in Mexico. Pediatr Infect Dis J 2011; 30(Suppl 1):S11-5.
8. Patel M, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009; 301:2243-51.
9. Molto Y, Cortes JE, De Oliveira LH, et al. Reduction of diarrheaassociated hospitalizations among children aged , 5 years in Panama following the introduction of rotavirus vaccine. Pediatr Infect Dis J 2011; 30(Suppl 1):S16-20.
10. Lanzieri TM, Costa I, Shafi FA, et al. Trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years of age in Brazil before and after human rotavirus vaccine introduction, 1998-2007. Pediatr Infect Dis J; 29:673-5.
11. Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999; 48:1007.
12. Colindres RE. GSK human rotavirus vaccine Rotarix: PASS Mexico study update. In: Presented at the Advisory Committee on immunization Practices Meeting. Atlanta, GA, 2010. Available at: http://www.cdc.gov/vaccines/recs/acip/ meetings.htm#slides. Accessed 16 March 2011.
13. Patel MM, López-Collada VR, Bulhoes MM, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011; 364:2283-92.
14. Buttery JP, Danchin MH, Lee KJ, et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011; 29: 3061-6.
15. World Health Organization. Statement on rotarix and rotateq vaccines and intussusception. Available at: http://www.who.int/vaccine-safety/topics/ rotavirus/rotarix-and-rotateq/intussusception-sep2010/en/index. html. Accessed 1 October 2010.
16. World Bank. 2009 World Development Indicators database. Available at: http://siteresources.worldbank.org/DATASTATISTICS/Resources/GNIPC.pdf. Accessed 15 November 2010.
17. Clark A, Sanderson C. Timing of children's vaccinations in 45 lowincome and middle-income countries: an analysis of survey data. Lancet 2009; 373:1543-9.
18. World Health Organization and Unicef. Immunization coverage rates. Available at: http://www.who.int/immunization-monitoring/routine/immunization- coverage/en/index4.html. Accessed 30 October 2010.
19. World Health Organization. Meeting of the immunization Strategic Advisory Group of Experts, April 2009-conclusions and recommendations. Wkly Epidemiol Rec 2009; 84:220-36.
20. Tate JE, Simonsen L, Viboud C, et al. Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics 2008; 121:e1125-32.
21. Abate H, Linhares AC, Venegas G, et al. A multi-center study of intussusception in Latin America: first year results (abstract). In: Presented at International Congress of Pediatrics conference. Cancun, Mexico, 2004.
22. Buettcher M, Baer G, Bonhoeffer J, Schaad UB, Heininger U. Three-year surveillance of intussusception in children in Switzerland. Pediatrics 2007; 120:473-80.
23. Chen YE, Beasley S, Grimwood K. Intussusception and rotavirus associated hospitalisation in New Zealand. Arch Dis Child 2005; 90: 1077-81.
24. Fischer TK, Bihrmann K, Perch M, et al. Intussusception in early childhood: a cohort study of 1.7 million children. Pediatrics 2004; 114:782-5.
25. Gay N, Ramsay M, Waight P. Rotavirus vaccination and intussusception. Lancet 1999; 354:956.
26. Ho WL, Yang TW, Chi WC, Chang HJ, Huang LM, Chang MH. Intussusception in Taiwanese children: analysis of incidence, length of hospitalization and hospital costs in different age groups. J Formos Med Assoc 2005; 104:398-401.
27. Justice F, Carlin J, Bines J. Changing epidemiology of intussusception in Australia. J Paediatr Child Health 2005; 41:475-8.
28. Nelson EA, Tam JS, Glass RI, Parashar UD, Fok TF. Incidence of rotavirus diarrhea and intussusception in Hong Kong using standardized hospital discharge data. Pediatr Infect Dis J 2002; 21:701-3.
29. O'Ryan M, Lucero Y, Pena A, Valenzuela MT. Two year review of intestinal intussusception in six large public hospitals of Santiago, Chile. Pediatr Infect Dis J 2003; 22:717-21.
30. Perez-Schael I, Escalona M, Salinas B, Materan M, Perez ME, Gonzalez G. Intussusception-associated hospitalization among Venezuelan infants during 1998 through 2001: anticipating rotavirus vaccines. Pediatr Infect Dis J 2003; 22:234-9.
31. Saez-Llorens X, Guevara JN. Intussusception and rotavirus vaccines: what is the background risk? Pediatr Infect Dis J 2004; 23:363-5.
32. FDA. Information on Rotarix-Labeling revision pertaining to intussusception. Available at: http://www.fda.gov/BiologicsBloodVaccines/ Vaccines/ApprovedProducts/ucm226690.htm. Accessed 1 October 2010.
33. Patel M. Intussusception following administration of RV: PAHO study, Brazil and Mexico. Presentation at the Advisory Committee on immunization Practices meeting. Atlanta, GA, 2010.
34. de Oliveira LH, Danovaro-Holliday MC, Andrus JK, et al. Sentinel hospital surveillance for rotavirus in Latin American and Caribbean countries. J Infect Dis 2009; 200(Suppl 1):S131-9.
35. De la Hoz F, Alvis N, Narvaez J, Cediel N, Gamboa O, Velandia M. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia. Vaccine 2010; 28:3856-64.
36. Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T. Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries. Rev Panam Salud Publica 2007; 21:192-204.
37. Guardado JA, Clara WA, Turcios RM, et al. Rotavirus in El Salvador: an outbreak, surveillance and estimates of disease burden, 2000-2002. Pediatr Infect Dis J 2004; 23(Suppl 10):S156-60.
38. Ehrenkranz P, Lanata CF, Penny ME, Salazar-Lindo E, Glass RI. Rotavirus diarrhea disease burden in Peru: the need for a rotavirus vaccine and its potential cost savings. Rev Panam Salud Publica 2001; 10:240-8.
39. Caceres DC, Pelaez D, Sierra N, Estrada E, Sanchez L. Burden of rotavirus-related disease among children under five, Colombia, 2004. Rev Panam Salud Publica 2006; 20:9-21.
40. Sartori AM, Valentim J, de Soarez PC, Novaes HM. Rotavirus morbidity and mortality in children in Brazil. Rev Panam Salud Publica 2008; 23:92-100.
41. Amador JJ, Vasquez J, Orozco M, et al. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program. Int J Infect Dis 2010; 14:e592-5. Epub 22 Dec 2009.
42. Hasing ME, Trueba G, Baquero MI, et al. Rapid changes in rotaviral genotypes in Ecuador. J Med Virol 2009; 81:2109-13.
43. Bourdett-Stanziola L, Ortega-Barria E, Espinoza F. Rotavirus genotypes in Costa Rica, Nicaragua, Honduras and the Dominican Republic. Intervirology. 2011; 54:49-52. Epub 6 Aug 2010.
44. World Health Organisation (WHO). Global and national estimates of deaths under age five attributable to rotavirus infection: 2004 (as of 31 March 2006). Available at: http://www.who.int/immunization-monitoring/burden/rotavirus- estimates/en/. Accessed 11 May 2010.
45. Anh DD, Thiem VD, Fischer TK, et al. The burden of rotavirus diarrhea in Khanh Hoa Province, Vietnam: baseline assessment for a rotavirus vaccine trial. Pediatr Infect Dis J 2006; 25:37-40.
46. Bahl R, Ray P, Subodh S, et al. Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J Infect Dis 2005; 192(Suppl 1):S114-19.
47. Nelson EA, Tam JS, Yu LM, Glass RI, Parashar UD, Fok TF. Surveillance of childhood diarrhoeal disease in Hong Kong, using standardized hospital discharge data. Epidemiol Infect 2004; 132:619-26.
48. Wilopo SA, Soenarto Y, Bresee JS, et al. Rotavirus surveillance to determine disease burden and epidemiology in Java, Indonesia, August 2001 through April 2004. Vaccine 2009; 27(Suppl 5):F61-6.
49. Hsu VP, Abdul Rahman HB, Wong SL, et al. Estimates of the burden of rotavirus disease inMalaysia. J Infect Dis 2005; 192(Suppl 1):S80-6.
50. Chen KT, Chen PY, Tang RB, et al. Sentinel hospital surveillance for rotavirus diarrhea in Taiwan, 2001-2003. J Infect Dis 2005; 192(Suppl 1):S44-8.
51. Jiraphongsa C, Bresee JS, Pongsuwanna Y, et al. Epidemiology and burden of rotavirus diarrhea in Thailand: results of sentinel surveillance. J Infect Dis 2005; 192(Suppl 1):S87-93.
52. Jin Y, Ye XH, Fang ZY, et al. Molecular epidemic features and variation of rotavirus among children with diarrhea in Lanzhou, China, 2001-2006. World J Pediatr 2008; 4:197-201.
53. Putnam SD, Sedyaningsih ER, Listiyaningsih E, et al. Group A rotavirus-associated diarrhea in children seeking treatment in Indonesia. J Clin Virol 2007; 40:289-94.
54. Flem ET, Kasymbekova KT, Vainio K, et al. Rotavirus infection in hospitalized children and estimates of disease burden in Kyrgyzstan, 2005-2007. Vaccine 2009; 27(Suppl 5):F35-9.
55. Ceyhan M, Alhan E, Salman N, et al. Multicenter prospective study on the burden of rotavirus gastroenteritis in Turkey, 2005-2006: a hospital-based study. J Infect Dis 2009; 200(Suppl 1):S234-8.
56. Podkolzin AT, Fenske EB, Abramycheva NY, et al. Hospital-based surveillance of rotavirus and other viral agents of diarrhea in children and adults in Russia, 2005-2007. J Infect Dis 2009; 200(Suppl 1): S228-33.
57. Wu FT, Liang SY, Tsao KC, et al. Hospital-based surveillance and molecular epidemiology of rotavirus infection in Taiwan, 2005-2007. Vaccine 2009; 27(Suppl 5):F50-4.
58. Soenarto Y, Aman AT, Bakri A, et al. Burden of severe rotavirus diarrhea in Indonesia. J Infect Dis 2009; 200(Suppl 1):S188-94.
59. Eesteghamati A, Gouya M, Keshtkar A, et al. Sentinel hospital-based surveillance of rotavirus diarrhea in Iran. J Infect Dis 2009; 200(Suppl 1): S244-7.
60. Jenney A, Tikoduadua L, Buadromo E, et al. The burden of hospitalised rotavirus infections in Fiji. Vaccine 2009; 27(Suppl 5):F108-11.
61. Moe K, Thu HM, Oo WM, et al. Genotyping of rotavirus isolates collected from children less than 5 years of age admitted for diarrhoea at the Yangon children's hospital, Myanmar. Vaccine 2009; 27(Suppl 5): F89-92.
62. Sherchand JB, Nakagomi O, Dove W, et al. Molecular epidemiology of rotavirus diarrhea among children aged , 5 years in Nepal: predominance of emergent G12 strains during 2 years. J Infect Dis 2009; 200(Suppl 1):S182-7.
63. Flem ET, Musabaev E, Juraev R, et al. Rotavirus gastroenteritis in Uzbekistan: implications for vaccine policy in central Asia. J Infect Dis 2009; 200(Suppl 1):S154-9.
64. Aloun DS, Nyambat B, Phetsouvanh R, et al. Rotavirus diarrhoea among children aged less than 5 years at Mahosot hospital, Vientiane, Lao PDR. Vaccine 2009; 27(Suppl 5):F85-8.
65. Nyambat B, Meng CY, Vansith K, et al. Hospital-based surveillance for rotavirus diarrhoea in Phnom Penh, Cambodia, March 2005 through February 2007. Vaccine 2009; 27(Suppl 5):F81-4.
66. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22.
67. Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011; 17: 7-15.
68. Correia JB, Patel MM, Nakagomi O, et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis 2010; 201:363-9.
69. Linhares AC, Velazquez FR, Perez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008; 371:1181-9.
70. Colindres R. Intussusception following administration of rotavirus 620 vaccine (RV): GSK study, Mexico. Presentation at the Advisory Committee on immunization Practices meeting. Atlanta, GA, 2010.
71. World Health Organization. Meeting of the Strategic Advisory Group of Experts on immunization, October 2009-conclusions and recommendations. Wkly Epidemiol Rec 2009; 84:518.
72. Simonsen L, Viboud C, Elixhauser A, Taylor RJ, Kapikian AZ. More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis 2005; 192(Suppl 1):S36-43.
73. Patel MM, Clark AD, Glass RI, et al. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine 2009; 27:2916-22.